Catherine Jomary

Catherine Jomary has over 20 years’ experience in cell and gene therapy, and regenerative medicine, within the academic, biotechnology, CDMO & pharmaceutical sectors. She holds a PhD in Neuropharmacology and was a Postdoctoral Research fellow at the Montreal Neurological Institute-Hospital at Mc Gill University, at John Hopkins Medical School, and at the University of Texas Medical School. She was awarded the UK Wellcome Trust Value in People Award, a Marie Curie Fellowship, a Medical Research Council of Canada Fellowship, and a “Fondation Recherche Médicale Française” post-doctoral research Fellowship. She has managed pre-clinical, clinical and commercial phases cell and gene therapy programs (pre-clinical, Phase I/II/III), and commercial launch (cell therapy and gene therapy products). She has experience of product and process CMC life cycle management including commercial pre-launch, launch and post approval of cell and gene therapy products (FDA, EMA, regulatory submission dossiers- IND, IMPD, BLA, and MMA). She provides the interface between the customer, supply chain, quality, business development, operations, and regulatory to deliver and execute client contracts to manufacture cell and gene therapy products.